Abstract
Glioblastoma multiforme (GBM) is the most aggressive type of brain tumor, characterized by excessive cell proliferation, resistance to apoptosis, and invasiveness. Due to resistance to currently available treatment options, the prognosis for patients with GBM is very dismal. The activation of gastrin-releasing peptide receptors (GRPR) stimulates GBM cell proliferation, whereas GRPR antagonists induce antiproliferative effects in in vitro and in vivo experimental models of GBM. However, the role of GRPR in regulating other aspects of GBM cell function related to tumor progression remains poorly understood, and previous studies have not used RNA interference techniques as tools to examine GRPR function in GBM. Here, we found that stable GRPR knockdown by a lentiviral vector using a short hairpin interfering RNA sequence in human A172 GBM cells resulted in increased cell size and altered cell cycle dynamics consistent with cell senescence. These changes were accompanied by increases in the content of p53, p21, and p16, activation of epidermal growth factor receptors (EGFR), and a reduction in p38 content. These results increase our understanding of GRPR regulation of GBM cells and further support that GRPR may be a relevant therap...Continue Reading
References
Nov 1, 1973·Journal of the National Cancer Institute·D J GiardW P Parks
Apr 1, 1995·Experimental Cell Research·K S Kulju, J M Lehman
Jan 1, 1993·Journal of Molecular Neuroscience : MN·J StaleyT W Moody
Jun 20, 1997·Molecular and Cellular Endocrinology·T R SharifM Sharif
Dec 22, 1999·Oncogene·H KiarisK Groot
Feb 19, 2000·The Prostate·B SunM Martinez
Mar 4, 2000·Oncogene·M J Ciesielski, R A Fenstermaker
Jun 8, 2001·Genes & Development·E A MaherR A DePinho
Mar 11, 2005·The New England Journal of Medicine·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Mar 14, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D B CornelioG Schwartsmann
Aug 2, 2007·Nature Reviews. Molecular Cell Biology·Judith Campisi, Fabrizio d'Adda di Fagagna
Dec 7, 2007·Pharmacological Reviews·R T JensenR V Benya
Jan 15, 2008·Oncogene·S Courtois-CoxK Cichowski
May 14, 2008·Current Neurovascular Research·Debora Gazzana FloresRafael Roesler
May 24, 2008·Oncology·Daniela Baumann CornelioGilberto Schwartsmann
Aug 2, 2008·The New England Journal of Medicine·Patrick Y Wen, Santosh Kesari
Aug 23, 2008·Oncology·Caroline Brunetto FariasRafael Roesler
Aug 30, 2008·Proceedings of the National Academy of Sciences of the United States of America·Jingbo QiaoDai H Chung
Jan 9, 2009·Journal of Neuro-oncology·Marianne Schrader de OliveiraRafael Roesler
Mar 24, 2009·Cancer Biology & Therapy·Yuichi SatoTakashi Sawai
Oct 7, 2009·Current Stem Cell Research & Therapy·Debora Gazzana FloresRafael Roesler
Mar 10, 2010·Brain Research Bulletin·Debora Gazzana FloresRafael Roesler
Nov 26, 2010·Current Opinion in Genetics & Development·Judith Campisi
Jun 1, 2012·Experimental Dermatology·Naoko OhtaniEiji Hara
Aug 21, 2012·PloS One·Eduardo C Filippi-ChielaGuido Lenz
Sep 21, 2013·Cell Cycle·Christoph GarbersJürgen Scheller
Oct 15, 2013·Cell·Cameron W BrennanUNKNOWN TCGA Research Network
Jan 1, 2014·Archives of Pathology & Laboratory Medicine·Jane MatteiGilberto Schwartsmann
May 14, 2014·Trends in Biochemical Sciences·Yingxi XuPeiqing Sun
Sep 16, 2014·Journal of Geriatric Oncology·Domenico CoppolaSteven Brem
Citations
Nov 11, 2016·Molecular Neurobiology·Viviane Rösner AlmeidaRafael Roesler
Apr 7, 2018·Glia·Sara Castro-SánchezIsabel Lastres-Becker
Aug 10, 2018·PloS One·Julie VéritéThierry Janet
Nov 10, 2017·Current Opinion in Endocrinology, Diabetes, and Obesity·Xiangping QuRujiao Liu
Sep 4, 2019·European Journal of Nuclear Medicine and Molecular Imaging·Lucia BarattoAndrei Iagaru
Jan 25, 2020·Biochimica Et Biophysica Acta. General Subjects·Jin Wook HwangAli G Turhan
Jul 14, 2021·Cancer Investigation·Qin XiaLei Dong
Sep 4, 2021·Materials Science & Engineering. C, Materials for Biological Applications·Banendu Sunder DashJyh-Ping Chen